DNA suspension arrays: Silencing discrete artifacts for high-sensitivity applications

PLoS ONE

Volumn 5, Issue 11, 2010, Pages

  Lalonde, Matthew S ^a   Arts, Eric J ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGONUCLEOTIDE; ANTIVIRUS AGENT; DNA; POL PROTEIN;

ANTIVIRAL RESISTANCE; ARTICLE; CODON; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA MICROARRAY; DNA PROBE; DNA TEMPLATE; GENE MUTATION; GENE SILENCING; GENETIC MODEL; GENETIC VARIABILITY; MICROARRAY ANALYSIS; PROTEIN SECONDARY STRUCTURE; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; ARTIFACT; DRUG EFFECT; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; METHODOLOGY; MUTATION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; STANDARD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ANTIVIRAL AGENTS; ARTIFACTS; BASE SEQUENCE; DNA; DRUG RESISTANCE, VIRAL; HIV-1; HUMANS; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POL GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 78149476214     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015476     Document Type: Article

References (20)

1. Dent AE, Yohn CT, Zimmerman PA, Vulule J, Kazura JW, et al. (2007) A polymerase chain reaction/ligase detection reaction fluorescent microsphere assay to determine Plasmodium falciparum MSP-119 haplotypes. Am J Trop Med Hyg 77: 250-255.
2. McNamara DT, Kasehagen LJ, Grimberg BT, Cole-Tobian J, Collins WE, et al. (2006) Diagnosing infection levels of four human malaria parasite species by a polymerase chain reaction/ligase detection reaction fluorescent microspherebased assay. Am J Trop Med Hyg 74: 413-421.
3. Einstein MH, Leanza S, Chiu LG, Schlecht NF, Goldberg GL, et al. (2009) Genetic variants in TAP are associated with high-grade cervical neoplasia. Clin Cancer Res 15: 1019-1023.
4. Li J, Wang L, Mamon H, Kulke MH, Berbeco R, et al. (2008) Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing. Nat Med 14: 579-584.
5. Cai F, Chen H, Hicks CB, Bartlett JA, Zhu J, et al. (2007) Detection of minor drug-resistant populations by parallel allele-specific sequencing. Nat Methods 4: 123-125.
6. Taylor JD, Briley D, Nguyen Q, Long K, Iannone MA, et al. (2001) Flow cytometric platform for high-throughput single nucleotide polymorphism analysis. Biotechniques 30: 661-669.
7. Carson RT, Vignali DA (1999) Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay. J Immunol Methods 227: 41-52.
8. Villahermosa ML, Beck I, Perez-Alvarez L, Contreras G, Frenkel LM, et al. (2001) Detection and quantification of multiple drug resistance mutations in HIV-1 reverse transcriptase by an oligonucleotide ligation assay. J Hum Virol 4: 238-248.
9. Carnevale EP, Kouri D, DaRe JT, McNamara DT, Mueller I, et al. (2007) A multiplex ligase detection reaction-fluorescent microsphere assay for simultaneous detection of single nucleotide polymorphisms associated with Plasmodium falciparum drug resistance. J Clin Microbiol 45: 752-761.
10. DaRe JT, Kouri DP, Zimmerman PA, Thomas PJ (2010) Differentiating Plasmodium falciparum alleles by transforming Cartesian X,Y data to polar coordinates. BMC Genet 11: 57.
11. Cooper DA, Steigbigel RT, Gatell JM, Rockstroh JK, Katlama C, et al. (2008) Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection. N Engl J Med 359: 355-365.
12. Troyer RM, Lalonde MS, Fraundorf E, Demers KR, Kyeyune F, et al. (2008) A radiolabeled oligonucleotide ligation assay demonstrates the high frequency of nevirapine resistance mutations in HIV type 1 quasispecies of NVP-treated and untreated mother-infant pairs from Uganda. AIDS Res Hum Retroviruses 24: 235-250.
13. Markham NR, Zuker M (2008) UNAFold: software for nucleic acid folding and hybridization. Methods Mol Biol 453: 3-31.
14. Rahimian M, Miao Y, Wilson WD (2008) Influence of DNA structure on adjacent site cooperative binding. J Phys Chem B 112: 8770-8778.
15. Chen HB, Weng JM, Jiang K, Bao JS (1990) A new method for the synthesis of a structural gene. Nucleic Acids Res 18: 871-878.
16. Lalonde MS, Troyer RM, Syed AR, Bulime S, Demers K, et al. (2007) Sensitive oligonucleotide ligation assay for low-level detection of nevirapine resistance mutations in human immunodeficiency virus type 1 quasispecies. J Clin Microbiol 45: 2604-2615.
17. Pozhitkov AE, Tautz D, Noble PA (2007) Oligonucleotide microarrays: widely applied-poorly understood. Brief Funct Genomic Proteomic 6: 141-148.
18. Descamps D, Chazallon C, Loveday C, Bacheler L, Goodall R, et al. (2009) Resistance and virological response analyses in a three initial treatment strategy trial: a substudy of the INITIO trial. HIV Clin Trials 10: 385-393.
19. Varghese V, Shahriar R, Rhee SY, Liu T, Simen BB, et al. (2009) Minority variants associated with transmitted and acquired HIV-1 nonnucleoside reverse transcriptase inhibitor resistance: implications for the use of second-generation nonnucleoside reverse transcriptase inhibitors. J Acquir Immune Defic Syndr 52: 309-315.
20. Palmer S, Boltz V, Martinson N, Maldarelli F, Gray G, et al. (2006) Persistence of nevirapine-resistant HIV-1 in women after single-dose nevirapine therapy for prevention of maternal-to-fetal HIV-1 transmission. Proc Natl Acad Sci U S A 103: 7094-7099.